Relationships Between Times to Testosterone and Prostate-Specific Antigen Rises During the First Off-Treatment Interval of Intermittent Androgen Deprivation are Prognostic for Castration Resistance in Men With Nonmetastatic Prostate Cancer
Kevin F Kuo, Rachel A. Hunter‐Merrill, Roman Gulati et al. · Clinical Genitourinary Cancer · 2014
Cited by 15 works. doi:10.1016/j.clgc.2014.08.003
Authors
- Kevin F Kuo
- Rachel A. Hunter‐Merrill
- Roman Gulati
- Suzanne P Hall
- Teresa E Gambol
- Celestia S. Higano
- Evan Y. Yu
References
- Natural History of Progression After PSA Elevation Following Radical Prostatectomy
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
- Risk of Prostate Cancer–Specific Mortality Following Biochemical Recurrence After Radical Prostatectomy
- Surrogate End Point for Prostate Cancer-Specific Mortality After Radical Prostatectomy or Radiation Therapy
- Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth
- Preoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy
- Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy
- Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy
- Memorial Sloan Kettering Cancer Center
- Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy